KRAS and neoplasm: In both univariate and multivariate analyses, a high rate of KRAS exon 2 mutation was associated with the following factors: female sex, advanced age, right-colon tumor, high carcinoembryonic antigen (CEA) levels, stage IV tumor, tumor type histology, and extranodal tumor deposit.